New study tests monthly shot to help people stop using fentanyl

NCT ID NCT06726200

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study compares a once-monthly injection of buprenorphine to daily sublingual buprenorphine for treating opioid use disorder in people who use fentanyl or other strong synthetic opioids. About 60 adults aged 18โ€“65 will be enrolled and followed for 4 weeks after starting treatment. The goal is to see which approach leads to more days without drug use and fewer relapses.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OPIOID-USE DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Substance Treatment and Research Service

    RECRUITING

    New York, New York, 10019, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.